April 8th 2009 | Biologics, Immune system | 1 Comment
Genentech has decided to remove Raptiva (efalizumab) from the US market. Raptiva will become unavailable in June, 2009.
All psoriasis patients currently on Raptiva should see their physician at once and not stop taking Raptiva without consulting their physician, as significant worsening of psoriasis can occasionally occur with an abrupt withdrawal of the drug.
Raptiva was
READ THE FULL POST
February 24th 2009 | Biologics, Immune system | 0 Comments
Raptiva is being pulled from the US market as of June 2009 due to safety issues. **See your physician before stopping Raptiva treatment.** More info at Raptiva.com.
November 17th 2008 | Biologics, Immune system | 0 Comments
From a Genentech news release:
Genentech, Inc. (NYSE:DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform dermatologists and neurologists of a 2nd case of progressive multifocal leukoencephalopathy (PML) which resulted in the death of a 73-year old woman who had received Raptiva (efalizumab) for approximately four years for treatment of
READ THE FULL POST
